Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer

APMIS

Volumn 121, Issue 10, 2013, Pages 919-925

  Qiu, Wensheng ^a   Zhou, Fang ^a   Zhang, Qian ^a   Sun, Xiaoxiao ^a   Shi, Xiaoli ^a   Liang, Ye ^a   Wang, Xiumei ^a   Yue, Lu ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Expression sites; Gastric cancer; Nucleolin; Prognosis

Indexed keywords

NUCLEOLIN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISTANT METASTASIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GASTRECTOMY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RADICAL RESECTION; RECURRENCE RISK; SIGNET RING CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH CANCER; SURVIVAL TIME;

EXPRESSION SITES; GASTRIC CANCER; NUCLEOLIN; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CELL NUCLEOLUS; CYTOPLASM; FEMALE; GASTRECTOMY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHOSPHOPROTEINS; PROGNOSIS; RNA-BINDING PROTEINS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84884722597     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12131     Document Type: Article

References (25)

1. Inoue H, Ikeda H, Hosoya T, Yoshida A, Onimaru M, Suzuki M, et al. Endoscopic mucosal resection, endoscopic submucosal dissection, and beyond: full-layer resection for gastric cancer with nonexposure technique (CLEAN-NET). Surg Oncol Clin N Am 2012;21:129-40.
2. Cammerer G, Formentini A, Karletshofer M, Henne-Bruns D, Kornmann M. Evaluation of important prognostic clinical and pathological factors in gastric cancer. Anticancer Res 2012;32:1839-42.
3. Lin F, Wu WL. Surgical treatment for advanced gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 2011;14:81-3.
4. Sun XD, Mu R, Zhou YS, Dai XD, Zhang SW, Huangfu XM, et al. Analysis of mortality rate of stomach cancer and its trend in twenty years in China. Zhonghua Zhong Liu Za Zhi 2004;26:4-9.
5. Li CH, Chen PJ, Chu HC, Huang TY, Shih YL, Chang WK, et al. Endoscopic submucosal dissection with the pulley method for early-stage gastric cancer (with video). Gastrointest Endosc 2011;73:163-7.
6. Tang Y, Dai Y, Huo J. Decreased expression of T-cadherin is associated with gastric cancer prognosis. Hepatogastroenterology 2012;59:1294-8.
7. Shu J, Li CG, Liu YC, Yan XC, Xu X, Huang XE, et al. Comparison of serum tumor associated material (TAM) with conventional biomarkers in cancer patients. Asian Pac J Cancer Prev 2012;13:2399-403.
8. Abdelmohsen K, Gorospe M. RNA-binding protein nucleolin in disease. RNA Biol 2012;9:11531-44.
9. Galzio R, Rosati F, Benedetti E, Cristiano L, Aldi S, Mei S, et al. Glycosilated nucleolin as marker for human gliomas. J Cell Biochem 2012;113:571-9.
10. Hoja-Lukowicz D, Przybylo M, Pochec E, Drabik A, Silberring J, Kremser M, et al. The new face of nucleolin in human melanoma. Cancer Immunol Immunother 2009;58:1471-80.
11. Tajrishi MM, Tuteja R, Tuteja N. Nucleolin: the most abundant multifunctional phosphoprotein of nucleolus. Commun Integr Biol 2011;4:267-75.
12. Krust B, El Khoury D, Nondier I, Soundaramourty C, Hovanessian AG. Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type. BMC Cancer 2011;11:333.
13. Kikuchi S, Futawatari N, Sakuramoto S, Katada N, Yamashita K, Shibata T, et al. Comparison of staging between the old (6th edition) and new (7th edition) TNM classifications in advanced gastric cancer. Anticancer Res 2011;31:2361-5.
14. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012;13:790-801.
15. Dai M, Ren JS, Li N, Li Q, Yang L, Chen YH. Estimation and prediction on cancer related incidence and mortality in China, 2008. Zhonghua Liu Xing Bing Xue Za Zhi 2012;33:57-61.
16. Park JM, Kim JH, Park SS, Kim SJ, Mok YJ, Kim CS. Prognostic factors and availability of D2 lymph node dissection for the patients with stage II gastric cancer: comparative analysis of subgroups in stage II. World J Surg 2008;32:1037-44.
17. Miniard AC, Middleton LM, Budiman ME, Gerber CA, Driscoll DM. Nucleolin binds to a subset of selenoprotein mRNAs and regulates their expression. Nucleic Acids Res 2010;38:4807-20.
18. Xu Z, Joshi N, Agarwal A, Dahiya S, Bittner P, Smith E, et al. Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest. J Neurooncol 2012;108:59-67.
19. Tate A, Isotani S, Bradley MJ, Sikes RA, Davis R, Chung LW, et al. Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells. BMC Cancer 2006;6:197.
20. Suganuma M, Watanabe T, Yamaguchi K, Takahashi A, Fujiki H. Human gastric cancer development with TNF-alpha-inducing protein secreted from Helicobacter pylori. Cancer Lett 2012;322:133-8.
21. Watanabe T, Hirano K, Takahashi A, Yamaguchi K, Beppu M, Fujiki H, et al. Nucleolin on the cell surface as a new molecular target for gastric cancer treatment. Biol Pharm Bull 2010;33:796-803.
22. Watanabe T, Tsuge H, Imagawa T, Kise D, Hirano K, Beppu M, et al. Nucleolin as cell surface receptor for tumor necrosis factor-alpha inducing protein: a carcinogenic factor of Helicobacter pylori. J Cancer Res Clin Oncol 2010;136:911-21.
23. Xie Z, Jiang Y, Liao EY, Chen Y, Pennypacker SD, Peng J, et al. PIKE mediates EGFR proliferative signaling in squamous cell carcinoma cells. Oncogene 2012;31:5090-8.
24. Grinstein E, Wernet P. Cellular signaling in normal and cancerous stem cells. Cell Signal 2007;19:2428-33.
25. Peng L, Liang J, Wang H, Song X, Rashid A, Gomez HF, et al. High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin Cancer Res 2010;16:3734-42.